DongKoo Bio & Pharma Co., Ltd.

KOSDAQ:A006620 Rapporto sulle azioni

Cap. di mercato: ₩136.8b

DongKoo Bio & Pharma Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Cho Yong-Jun

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO30.6%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Nessun aggiornamento

Recent updates

More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Aug 23
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

Jul 25
Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Mar 27
We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

AMMINISTRATORE DELEGATO

Cho Yong-Jun

no data

Mandato

Mr. Cho Yong-Jun serves as the President at DongKoo Bio & Pharma Co., Ltd. and serves as its Chief Executive Officer.